Impact of Screening Mammography on Treatment in Women Diagnosed with Breast Cancer
Screening mammography reduces breast cancer mortality; however, screening recommendations, ordering, and compliance remain suboptimal and controversies regarding the value of screening persist. We evaluated the influence of screening mammography on the extent of breast cancer treatment.
Patients ≥ 40 years of age diagnosed with breast cancer from September 2008 to May 2016 at a single institution were divided into two groups: those with screening 1–24 months prior to diagnosis, and those with screening at 25+ months, including patients with no prior mammography. The association between the two groups and various clinical factors were assessed using logistic regression models. Subgroup analysis was performed based on age groups.
Analysis included 1125 patients, 819 (73%) with screening at 1–24 months, and 306 (27%) with screening at 25+ months, including 65 (6%) who never had mammography. Overall, patients in the 25+ months group were more likely to receive chemotherapy [odds ratio (OR) 1.51, p = 0.0040], undergo mastectomy (OR 1.32, p = 0.0465), and require axillary dissection (AD; OR 1.66, p = 0.0045) than those in 1–24 months group. On subgroup analysis, patients aged 40–49 years with no prior mammography were more likely to have larger tumors (p = 0.0323) and positive nodes (OR 4.52, p = 0.0058), undergo mastectomy (OR 3.44, p = 0.0068), undergo AD (OR 4.64, p = 0.0002), and require chemotherapy (OR 2.52, p = 0.0287) than the 1–24 months group.
Screening mammography is associated with decreased stage at diagnosis and receipt of less-extensive treatment. This was evident in all groups, including the 40–49 years age group, where controversy exists on whether screening is even necessary.
Authors have no financial disclosures.
- 5.Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1-breast cancer detection and death rates among women aged 40–49 years. Can Med Assoc J. 1992;147:1459–76.Google Scholar
- 7.Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Follow-up after 11 years: update of mortality results in the Stockholm mammographic screening trial Breast Cancer. Res Treat. 1997;45:263–70.Google Scholar
- 9.Centers for Disease Control and Prevention, National Center for Health Statistics. Health, United States, 2016: with chartbook on long-term trends in health. 2017. https://www.cdc.gov/nchs/data/hus/hus16.pdf. Accessed 17 Mar 2018.
- 10.National Comprehensive Cancer Network (NCCN) Guidelines. NCCN clinical practice guidelines in oncology. Breast cancer screening and diagnosis. 2017. https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf. Accessed 17 Mar 2018.
- 12.United States Preventive Services Task Force. Breast cancer: screening recommendations. 2016. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/breast-cancer-screening. Accessed 17 Mar 2018.
- 15.American Cancer Society Cancer. Cancer treatment and survivorship facts and figures 2014–2015. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/cancer-treatment-and-survivorship-facts-and-figures-2014-2015.pdf. Accessed 17 Mar 2018.
- 16.American Cancer Society. Breast cancer facts and figures 2017–2018. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2017-2018.pdf. Accessed 17 Mar 2018.
- 30.National Comprehensive Cancer Network (NCCN) guidelines. NCCN clinical practice guidelines in oncology. Invasive breast cancer. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 20 Apr 2018.